References
1. Kourtis AK, Lee FK, Abrams EJ, Jamieson DJ, Bulterys M. Mother-to-child transmission of HIV-1: timing and implications for prevention. Lancet Infect Dis 2006. 6726–732.
2. Connor EM, Sperling RS, Gelber R. Reduction of maternalinfant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994. 3311173–1180.
3. Guay L, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M, Emel L, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Dransfield K, Bray D, Mmiro F, Jackson JB. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomized trial. Lancet 1999. 354795–802.
4. Mandelbrot L. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA 2001. 2852083–2093.
5. The European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomized clinical trial. Lancet 1999. 3531035–1039.
6. Mofenson LM. the Committee on Pediatric AIDS. Technical report: perinatal human immunodeficiency virus testing and prevention of transmission. Pediatrics 2000. 106e88.
7. Wade NA, Birkhead GS, French PT. Short courses of zidovudine and perinatal transmission of HIV. N Engl J Med 1999. 3401040–1043.
8. Henderson DK, Fahey BJ, Willy M, Schmitt JM, Carey K, Koziol DE, Lane HC, Fedio J, Saah AJ. Risk of occupational exposure of human immunodeficiency virus type 1(HIV-1) associated with clinical exposures: A prospective evaluation. Ann Intern Med 1990. 113740–746.
9. Do AN, Ciesielski CA, Metler RP, Hammett TA, Li J, Fleming PL. Occupationally acquired human immunodeficiency virus (HIV) infection : national case surveillance data during 20 years of the HIV epidemics in the United States. Infect Control Hosp Epidemiol 2003. 2486–96.
10. Choi SM, Lee JY, Oh HS, Park ES, Kim SW, Kim YR, Shin DH, Chung MH, Cho GJ, Song JH, Woo JH, Kim JM, Choe KW, Park SC, Kang MW. Survey of HIV exposure and postexposure prophylaxis among health care workers in Korea. Korean J Nosocomial Infect Control 2002. 765–73.
11. Cardo DM, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, Abiteboul D, Heptonstall J, Ippolito G, Lot F, McKibben PS, Bell DM. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med 1997. 3371485–1490.
12. Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996. 1753–85.
13. Panlilio AL, Cardo DM, Grohskopf LA, Heneine W, Ross CS. Updated U.S. Public Health Service guidelines for the management of occupational exposure to HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep 2005. 541–17.
15. CDC. Update: Transmission of HIV infection during an invasive dental procedure-Florida. MMWR 1991. 4021–33.
16. Lowenfels AB, Wormser G. Risk of transmission of HIV from surgeon to patient. N Engl J Med 1991. 325888–889.
17. Pinkerton SD, Martin JN, Roland ME, Katz MH, Coates TJ, Kahn JO. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus. Arch Intern Med 2004. 16446–54.
18. Del Rio C, Curran JW. In : Mandell GL, Bennet JE, Dolin R, eds. Epidemiology and prevention of acquired immunodeficiency syndrome and human immunodeficiency virus infection. Principle and practice of infectious diseases 2005. 6th edth ed. Philadelphia: Elsevier; 1477–1506.
19. Schwebke JR. Abnormal vaginal flora as a biological risk factor for acquisition of HIV infection and sexually transmitted diseases. J Infect Dis 2005. 1921315–1317.
20. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: ANRS 1265 Trial. PLoS Med 2005. 2e298.
21. Stein ZA. Vaginal microbicides and prevention of HIV infection. Lancet 1994. 343362–363.
22. Smith DK, Grohskopf LA, Black RJ, Auerbach JD, Veronese F, Struble KA, Cheever L, Johnson M, Paxton LA, Onorato IM, Greenberg AE. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Service. MMWR Recomm Rep 2005. 541–20.
23. Katzenstein TL, Dickmeiss E, Aladdin H, Hede A, Nielsen C, Nielsen H, Jorgensen LB, Gerstoft J. Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxis. Ann Intern Med 2000. 13331–34.
24. Bloch M, Carr A, Vasak E, Cunningham P, Smith D. The use of HIV post-exposure prophylaxis after successful artificial insemination. Am J Obst Gyencol 1999. 181760–761.